The Korea SMEs and Startups Agency (KOSME) has a mission to expand the influence of Korean-founded business into foreign markets. Selected as one of ten global locations, MATTER and KOSME launched the U.S. Market Adoption Program in 2021 with five Korean healthcare companies aimed at U.S. market deployment.
Since 2021, MATTER has equipped ten Korean companies with a network of critical resources, mentorship and programming to advance their product, sales and fundraising in the U.S. healthcare ecosystem.
MATTER also produces multiple showcase events to facilitate SME exposure to potential partners, investors and industry influencers. The companies continue to benefit beyond the program with a one-year MATTER membership.
The following companies have participated in the U.S. Market Adoption Program:
2023:
Deep Bio
Medipixel
PROTEINA
VUNO
2022:
AIRS Medical
Emocog
RF Medical
Soundable Health
Thyroscope
2021:
Mediwhale
Xandar Kardian
Soundable Health
Bertis
CREDO
